Using flow cytometric analysis, we found that the number of CD11b+Gr-1hi MDSCs and CD4+CD25+Foxp3+ Treg cells within the tumor microenvironment was remarkably reduced in CQ-treated tumor-bearing mice, compared with those in the control group (Fig. 7a–d). This evidence concerns the gene ITGAM and neoplasm.